Mr. Fundarò has been Genextra’s chief financial officer since its inception in 2004 and he has served as a member of the board of directors of Genextra’s portfolio companies. In particular, he is currently Chairman of Intercept Pharmaceutical and Innovheart, Director of Erydel, Managing Director of Congenia. In addition, Mr. Fundarò is also a founder and a Board Member of the Italian Angels for Biotech. Before joining Genextra Mr. Fundarò was in charge of finance and strategic planning for Fastweb from 2000 to 2004. Previously, he worked in London for investment banks, including Salomon Smith Barney (now Citigroup) and Donaldson Lufkin & Jenrette (now Credit Suisse). Mr. Fundarò has a degree in Business Management from Bocconi University in Milan, Italy.